ADIPOQ and left ventricular hypertrophy: Adiponectin has been recently described to be an anti-inflammatory and cardioprotective cytokine as low levels of adiponectin have been revealed in patients with severe coronary artery disease (CAD) and left ventricular hypertrophy with diastolic dysfunction [15,16,17].